Timothy E. Wilens, MD

February 15, 2027, 08:45–09:05

Discusses ADHD in relation to substance use risk and treatment.

ADHDSubstance Use Disorders

February 15, 2027, 09:05–09:25

Examines substance use and addiction among athletes.

Substance Use Disorders

February 15, 2027, 09:25–09:55

Panel discussion on adolescent substance use topics.

Child & AdolescentSubstance Use Disorders

February 15, 2027, 10:10–10:30

Reviews psychedelics in the context of addiction.

PsychedelicsSubstance Use Disorders

February 15, 2027, 10:30–10:50

Addresses benzodiazepine misuse and addiction.

Benzodiazepines & SedativesSubstance Use Disorders

February 16, 2027, 08:05–08:25

First of two talks on cannabis in the context of substance use disorders.

Cannabis & Cannabinoids

February 16, 2027, 08:45–09:15

Panel discussion following the cannabis talks.

Cannabis & Cannabinoids

November 4, 2026

Managing ADHD complicated by executive dysfunction and psychiatric comorbidity, with practical treatment-optimization tactics.

ADHDChild & Adolescent

October 29, 2026

The Lifelong Learning Committee's annual literature-review institute, in which seven experts present and discuss roughly 37 vetted papers from the past year that practicing child psychiatrists should know.

Child & Adolescent

October 29, 2026, 10:00–12:00

Presents longitudinal HEAL study findings on whether treating depression in youth lowers later substance use disorder risk.

Child & AdolescentDepressionSubstance Use Disorders

October 29, 2026, 10:00–12:00

Symposium on how longitudinal studies inform understanding of psychiatric outcomes in children and adolescents.

ADHDBipolar DisorderChild & Adolescent

October 29, 2026, 14:30–16:30

Explores factors associated with ADHD medication use among youth and adults who also have substance use disorders.

ADHDStimulants & ADHD MedicationsSubstance Use Disorders

October 29, 2026, 16:00–18:00

Reviews new developments in ADHD, substance use, psychosis, and psychotropic medication use in preschool-aged children.

ADHDChild & AdolescentSchizophrenia & PsychosisSubstance Use Disorders

October 18, 2026

An update on ADHD pharmacotherapy across the lifespan.

ADHDStimulants & ADHD Medications

September 16, 2026

Frameworks for diagnostic clarification and treatment sequencing when ADHD co-occurs with anxiety, mood disorders, autism, or substance use, balancing symptom control against misuse and destabilization risks.

ADHDAnxiety DisordersAutism & Neurodevelopmental DisordersSubstance Use Disorders